TABLE 2.
Cardiac mass index (mg/g) | Left ventricular mass index (mg/g) | Renal mass index (mg/g) | |
SHRSP (n = 16–34) | 4.66 ± 0.40 | 3.64 ± 0.39 | 4.11 ± 0.25 |
WKY (n = 12–32) | 3.48 ± 0.26a | 2.52 ± 0.20a | 2.87 ± 0.23a |
SP.WKYGla3a (n = 16–19) | 4.03 ± 0.28a | 3.04 ± 0.29a | 3.65 ± 0.20a |
SP.WKYGla3b (n = 6) | 4.47 ± 0.27 | 3.33 ± 0.33 | 3.78 ± 0.18 |
SP.WKYGla3c (n = 4–5) | 3.88 ± 0.12a | 2.79 ± 0.14a | 3.77 ± 0.12 |
SP.WKYGla3d (n = 7) | 4.07 ± 0.17a | 3.00 ± 0.11a | 3.77 ± 0.15 |
SP.WKYGla3e (n = 12–13) | 4.26 ± 0.30a | 3.12 ± 0.24a | 4.16 ± 0.40 |
SP.WKYGla3f (n = 7–11) | 4.72 ± 0.64 | 3.57 ± 0.66 | 4.25 ± 0.70 |
SP.WKYGla3g (n = 5–7) | 4.67 ± 0.40 | 3.28 ± 0.19 | 4.20 ± 0.62 |
P value | <0.001 | <0.001 | <0.001 |
SHRSP, stroke-prone spontaneously hypertensive; WKY, Wistar–Kyoto.
aStrain is significantly different from SHRSP.